Safety of Garcinia cambogia Extract in Healthy Volunteers: High-Dose Administration Study II

Journal of Oleo Science

Volumn 52, Issue 12, 2003, Pages 663-671

  Ishii, Yuri ^a   Kaneko, Izuru ^a   Shen, Manzhen ^a   Hayamizu, Kohsuke ^a   Shigematsu, Norihiro ^a   Tomi, Hironori ^b   Yoshino, Gen ^c   Shimasaki, Hiroyuki ^d  

^a Central Research Development Laboratory Fancl Corporation   (Japan)

^b NIPPON SHINYAKU CO LTD   (Japan)

^c TOHO UNIVERSITY   (Japan)

^d TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Garcinia; hydroxycitric acid (HCA); inihibin B

Indexed keywords

EID: 14944339952     PISSN: 13458957     EISSN: 13473352     Source Type: Journal    
DOI: 10.5650/jos.52.663     Document Type: Article

References (25)

1. The wealth of India (Raw Materials), CSIR, New Dehli, India. Vol. 4, 99-108 (1956).
2. G. WATT, Dictionary of the Economic Products of India. Peri-odical Export, New Dehli, India, Vol. 3, 464 (1972).
3. Y. S. LEWIS and S. NEELAKANTAN, (-)-Hydroxycitic Acid- The Principal Acid in the Fruits of Garcinia cambogia Desr., Phytochem., Vol. 4, 619-625 (1965).
4. A. C. SULLIVAN, M. SINGH, P. A. SRERE and J. P. GLUSKER, Reactivity and Inhibitor Potential of Hydroxycitrate Isomers with Citrate Synthase, Citrate Lyase and ATP Citrate Lyase., J Biol Chem., Vol. 10, 7583-7590 (1977).
5. J. A. WATSON, F. NARIE and J. M. LOWESTEIN, Tricarbally-late and Hydroxycitrate: Substrate and Inhibitor of ATP : Citrate Oxaloacetate Lyase., Arch Biochem Biophys., Vol. 135, 209-217 (1969).
6. A. A. CONTE, A Non-Prescription Alternative in Weigh Reduc-tion Therapy, The Bariatrician-summer, 17-19 (1993).
7. W. SERGIO, A Natural Food, the Malabar Tamarind, may be Effective in the Treatment of Obesity, Med Hypothesis, Vol. 27, 39-40 (1988).
8. R. R. RAMOS, J. L. F. SAENZ and C. F. J. A. AGUILAR, Investi-gation Medica Internacional, Vol. 22, 97-100 (1995).
9. K. HAYAMIZU, Y. ISHII, I. KANAKO, M. SHEN, H. SAKA-GUCHI, Y. OKUHARA, N. SHIGEMATSU, S. MIYAZAKI and H. SHIMASAKI, Effects of Long-term Administration of Garcinia Cambogia Extract on Visceral Fat Accumulation in Humans: A Placebo-controlled Blind Trial, J. Oleo Sci., Vol. 50, 43-50 (2001).
10. K. HAYAMIZU, Y. ISHII, N. SHIGEMATSU, Y. OKUHARA, H. TOMI, M. FURUSE, G. YOSHINO and H. SHIMASAKI, Safety of Garcinia cambogia Extract in Healthy Men: High-Doses Administration Study I, J. Oleo Sci., Vol. 52, 499-504 (2003).
11. R. S. CARROL, P. M. KOWASH, J. A. LOFGREN, R. H. SCHWALL and M. W. CHIN, In Vivo Regulation of FSH Syn-thesis by Inhibin and Activin, Endocrinology, Vol. 129, 3299-3304 (1991).
12. R. MEDHAMURTHY, M. D. CULLER, V. L. GAY, A. NEGRO-VILAR and Tm. PLANT, Evidence that Inhibin Plays a Major Role in the Regulation of Follicle-Stimulating Hormone Secre-tion in the Fully Adult Male Rhesus Monkey (Macaca mulatta), Endocrinology, Vol. 129, 389-395 (1991).
13. P. J. ILLINGROWTH, N. P. GROOME, W. BYRD, W. E. RAINEY, A. S. MCNEILLY, J. P. MATHER and W. J. BREMN-ER, Inhibin-B: a Likely Candidate for the Physiologically Important from of Inhibin in Men. J Clin Endocinol Metab., Vol. 81, 1321-1325 (1996).
14. W. KRAUSE and C. BOHRING, Inhibin B as a Marker of Sper-matogenesis. A New Dimension in Andrology, Hautarzt, Vol. 53, 5-10 (2002).
15. B. D. ANAWALT, R. A. BEBB, A. M. MATSUMOTO, N. P. GROOME, P. J. ILLNGWORTH, A. S. MCNEILLY and W. J. BREMNER, Serum Inhibin B Levels Reflect Sertoli cell Func-tion in Normal Men and Men with Testicular Dysfunction, J Clin Endocrinol Metab., Vol. 81, 3341-3345 (1996).
16. D. KLINGMULLER and G. HAIDL, Inhibin B in Men with Normal and Distubed Spermatogenesis, Hum Reprod., Vol. 12, 2376-2378 (1997).
17. T. K. JENSEN, A. M. ANDERSSON, N. H. HJOLLUND, T. SCHEIKE, H. KOLSTAD, A. GIWERCMAN, T. B. HENRIK-SEN, E. ERNST, J. P. BONDE, J. OLSEN, A. MCNEILLY, N. P. GROOME and N. E. SKAKKEBAEK, Inhibin B as a Serum Marker of Spermatogenesis: Correlation to Differences in Sperm Concentration and Follicle-Stimulating Hormone Levels. A Study of 349 Danish Men, J Clin Endocrinol Metab., Vol. 82, 4059-4063 (1997).
18. F. H. PIERIK, J. T. VREEBURG, T. STIJNEN, F. H. DE JONG and R. F. WEBER, Serum Inhibin B as a Marker of Spermatoge-nesis, J Clin Endocrinol Metab., Vol. 83, 3110-3114 (1998).
19. K. SATOH, Y. SAKAMOTO, A. OGATA, F. NAGAI, H. MIKURIYA, M. NUMAZAWA, K. YAMADA and N. AOKI, Inhibition of Aromatase Activity by Green Tea Extract Cathechins and Their Endocrinologiacal Effects of Oral Admini-stratuion in Rats, Food and Chemical Toxicology, Vol. 40, 925-933 (2002).
20. M. F. MCCARTY, Promotion of Hepatic Lipid Oxidation and Glucogenesis as A strategy for Appetite Control, Med Hypothe-ses, Vol. 42, 215-225 (1994).
21. S. FUJIOKA, Y. MATSUZAWA, K. TOKUNAGA and S. TARUI, Contribution of Intra-abdominal Fat Accumulation to the Impairment of Glucose and Lipid Metabolism in Human Obesity, Metabolism, Vol. 36, 54-59 (1987).
22. S. FUJIOKA, Y. MATSUZAWA, K. TOKUNAGA, T. KAWAMOTO, T. KOBATAKE, Y. KENO, K. KOTANI, S. YOSHIDA and S. TARUI, Improvement of Glucose and Lipid Metabolism Associated with Selective Reduction of Intra-abdominal Visceral Fat in Premenopausal Women with Visceral Fat Obesity, Int J Obes., Vol. 15, 853-859 (1991).
23. R. LEENEN, K. VAN DER KOOY, J. C. SEIDELL and P. DEURENBERG, Visceral Fat Accumulation Measured by Mag-netic Resonance Imaging in Relation to Serum Lipids in Obese Men and Women, Atherosclerosis, Vol. 94, 171-181 (1992).
24. T. NAKAMURA, K. TOKUNAGA, I. SHIMOMURA, M. NISHIDA, S. YOSHIDA, K. KOTANI, A. H. ISLAM, Y. KENO, T. KOBATAKE, Y. NAGAI, et al., Contribution of Visceral Fat Accumulation to the Development of Coronary Artery Disease in Non-obese Men, Atherosclerosis, Vol. 107, 239-246 (1994).
25. H. KANAI, K. TOKUNAGA, S. FUJIOKA, S. YAMASHITA, K. K. KAMEDA-TAKEMURA and Y. MATSUZAWA, Hyper-tension, Vol. 27, 125-129 (1996).